Biricodar: Difference between revisions
m Protected "Biricodar": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
||
Line 26: | Line 26: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
==Overview== | ==Overview== | ||
Line 36: | Line 36: | ||
*[http://clincancerres.aacrjournals.org/cgi/content/abstract/8/3/670 AARC article about the drug] | *[http://clincancerres.aacrjournals.org/cgi/content/abstract/8/3/670 AARC article about the drug] | ||
[[Category:Chemotherapeutic agents]] | [[Category:Chemotherapeutic agents]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WS}} | {{WS}} |
Latest revision as of 22:58, 8 August 2012
- "Incel" redirects here. The term is also sometimes used to refer to involuntary celibacy.
File:Biricodar.svg | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C34H41N3O7 |
Molar mass | 603.705 g/mol |
WikiDoc Resources for Biricodar |
Articles |
---|
Most recent articles on Biricodar |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Biricodar at Clinical Trials.gov Clinical Trials on Biricodar at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Biricodar
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Biricodar Discussion groups on Biricodar Directions to Hospitals Treating Biricodar Risk calculators and risk factors for Biricodar
|
Healthcare Provider Resources |
Causes & Risk Factors for Biricodar |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Overview
Biricodar (INN, codename VX-170, marketed as the dicitrate salt under the trade name Incel) is a pharmaceutical drug released by Vertex Pharmaceuticals in 1999 to help treat ovarian cancer patients.
External links
- Pages with script errors
- Pages with broken file links
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Chemotherapeutic agents